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A B S T R A C T
Background: Poor mental health after stroke is common and complex. We aimed to identify predictors of poor
wellbeing and to examine the overlap of poor wellbeing, fatigue, and depression.
Method: Consecutive first-ever ischemic stroke-patients filled in questionnaires on wellbeing, fatigue, and de-
pression at baseline and at one and six months. The World Health Organization 5-Item Wellbeing-Index (WHO-
5), the Major Depression Inventory, and the Multidimensional Fatigue Inventory were used. Patients were
genotyped according to serotonin-transporter gene polymorphisms. Multivariable logistic regression was used to
identify potential predictors of poor wellbeing (WHO-5 score <50). Overlap between wellbeing, fatigue, and
depression was examined using an Euler diagram.
Results: We included 919 patients. The prevalence of poor wellbeing was 279 (30.4%) six months after stroke.
Living alone at stroke onset was the strongest predictor of poor wellbeing with a mutually adjusted odds ratio of
1.53 (95% confidence interval (CI): 1.03 to 2.28) at one month and 1.77 (CI: 1.13 to 2.76) at six months. Severe
stroke at admission also predicted poor wellbeing at six months. Abnormal fatigue occurred in half and in-
corporated almost all patients with poor wellbeing. Less than 5% fulfilled the criteria for depression at any point
and almost all of these patients had poor wellbeing and abnormal fatigue. Antidepressants were used by 292
(31.8%) during follow-up.
Limitations: Cognitive impairment was not measured and could interact with wellbeing post-stroke.
Conclusion: Living alone strongly predicted poor wellbeing after stroke. Satisfactory mental health-recovery
seems to require psychosocial interventions when indicated in combination with antidepressant treatment.
1. Introduction
Many patients surviving a stroke suffer from mental and cognitive
impairment (Jokinen-Salmela et al., 2015). Post-stroke depression
(PSD) is common among stroke sequelae, reported to be present in
approximately 30% of stroke survivors at any given time (Hackett and
Pickles, 2014). PSD is associated with functional dependency as well as
increased mortality and morbidity, highlighting the importance of
identifying and treating the condition (S.A. et al., 1998). However,
stroke patients may not meet the formal diagnostic criteria for de-
pression but still face the challenges of poor wellbeing and a negative
impact of depressive symptoms on their recovery process. Furthermore,
patients’ wellbeing may be low despite otherwise effective
antidepressant treatment. A broader approach to mental health after
stroke, including a focus on wellbeing, therefore seems reasonable.
However, research in this field is sparse.
Different patient characteristics, such as physical disability and
stroke severity, have been associated with PSD (Towfighi et al., 2017).
PSD has also been associated with a well-described functional length
polymorphism (5-HTTLPR) in the serotonin transporter gene causing
different levels of gene transcription and thereby different levels of
serotonin transporters (Mak et al., 2013). The associations between
potential predictors, including serotonin transporter gene polymorph-
isms or any other genetic factors, and the broader concept of perceived
wellbeing after stroke remain to be studied. Furthermore, little is
known about the overlap and interactions of wellbeing, depression, and
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sequelae such as abnormal fatigue after stroke. Better understanding
what predisposes to poor wellbeing after stroke will enable us to more
efficiently identify patients at risk and potentially initiate relevant
preventive and therapeutic strategies.
In the present study, we therefore aimed to study potential pre-
dictors of wellbeing, including specific genetic polymorphisms in the
serotonin transporter gene, demographics, and several stroke-related
risk factors. Furthermore, patient-reported wellbeing, abnormal fatigue,
and depression, and the overlap between these entities will be visua-
lized in order to examine mental health after stroke.
2. Methods
We included consecutive first-ever ischemic stroke patients ad-
mitted to the Acute Stroke Unit at Aarhus University Hospital, Denmark
between October 2012 and July 2015 for genetic testing and six-month
follow-up. Patients were included within seven days from symptom
onset. The local ethics committee approved the study (study number
M20110281), and all participants gave written informed consent.
2.1. Data collection
Wellbeing was registered using the World Health Organization 5-
Item Wellbeing Index (WHO-5), a 5-item scale assessing the wellbeing
of subjects as a measure of mental health (Topp et al., 2015). The WHO-
5-score was dichotomized for logistic analysis with a poor outcome
defined as a score <50, which is also the recommended cut-off score
when screening for clinical depression (Topp et al., 2015). Depression
was evaluated using the 10-item Major Depression Inventory (MDI)
(Bech et al., 2001), and was defined as the presence of depressive
symptoms according to the International Classification of Diseases, 10th
Revision (ICD-10) corresponding to mild, moderate, or severe depres-
sion. Fatigue symptoms were registered using the 20-item Multi-
dimensional Fatigue Inventory (MFI) (Smets et al., 1995). In ac-
cordance with previous studies, we used the 4-item “general fatigue”
scale as an indicator for fatigue with a score >11 on the MFI being
defined as abnormal (Cumming et al., 2016; Holzner et al., 2003).
All questionnaires were filled in at the hospital upon inclusion.
During follow-up at one and six months, patients received, filled in, and
returned the questionnaires by mail or filled in questionnaires at hos-
pital visits. Patients were instructed to answer the questionnaires with
regard to the presence of symptoms during the previous two weeks. The
intention of the baseline questionnaires was to register symptoms prior
to stroke onset.
Baseline data were obtained from The Danish Stroke Registry at
inclusion to the study (Wildenschild et al., 2013). These data included
age, sex, co-morbidities, smoking habits, and sociodemographic in-
formation as well as stroke severity, measured using the Scandinavian
Stroke Scale (Multicenter trial of hemodilution in ischemic stroke–-
background and study protocol. Scandinavian Stroke Study Group,
1985). Examining patient charts at six months, we extracted informa-
tion on stroke sub-type according to the Trial of Org 10172 in Acute
Stroke Treatment (TOAST) classification (Adams et al., 1993) and le-
sion location according to the Oxfordshire classification (Bamford et al.,
1991). Finally, patients filled in a questionnaire on the use of anti-
depressant medication.
2.2. Genotyping
For genotyping of the serotonin transporter (SERT), DNA was ex-
tracted from whole blood samples using standard procedures.
Genotyping was performed on an ABI 3130 Prism Genetic Analyzer,
and the fluorescent peaks were analyzed using Genemapper version 4.0
(Applied Biosystems, Foster City, CA). All genotypes were checked in-
dependently by two experienced investigators to reduce the risk of
genotyping errors (Mortensen et al., 2018). We studied two
polymorphisms: the length variation (short=S/long=L) in the ser-
otonin-transporter-linked polymorphic region (5-HTTLPR) and a single-
nucleotide (A/G) polymorphism (rs25531). The genotypes were
grouped according to functional activity: SS, SLG and LGLG (low ex-
pression), SLA, LGLA (medium expression), and LALA (high expression).
2.3. Statistical analysis
Data are presented using numbers and percentages, or median and
interquartile range (IQR; Q1 and Q3) where relevant. Odds ratios (OR)
with 95% confidence intervals (CI) are calculated using logistic re-
gression models. Associations between potential predictors and poor
wellbeing were analyzed using univariate and multivariable logistic
regression mutually adjusting for the included predictor variables.
Imputation using chained equations on missing test scores was per-
formed for sensitivity analyses. In addition, we repeated the analyses
after excluding patients with depression and patients treated with an
antidepressant.
The overlap between poor wellbeing, depression, and fatigue was
examined using an Euler diagram.
Data were analyzed using R version 3.4.4 (R Core Team, 2015) with
RStudio (RStudio Team (2015)). Euler-diagrams were created using the
“eulerr” package (Larsson, 2018), and imputation was done using the
“mice” package (Buuren and Groothuis-Oudshoorn, 2011).
3. Results
A total of 919 first-ever ischemic stroke patients were included and
genotyped. The median age was 68 years, and 565 (61.5%) were males.
A total of 786 (85.5%) patients had mild to moderate stroke according
to a Scandinavian Stroke Scale (SSS) score of 45 to 58. Baseline char-
acteristics are presented in Table 1.
Poor wellbeing was present in 179 (20.9%) at baseline, in 211
(29.0%) at one month, and in 160 (24.7%) at six months. The overall
prevalence was 279 (30.4%) during follow-up. Predictors of poor
wellbeing at baseline and at one and six months are presented in
Table 2. The strongest association with wellbeing was living alone,
which predicted poor wellbeing at both one month (mutually adjusted
OR: 1.53, 95%, confidence interval (CI): 1.03 to 2.28) and six months
(mutually adjusted OR: 1.77, CI: 1.13 to 2.76). No independent pre-
dictors were observed at baseline. Smoking, vascular disease, female
sex, and low Body Mass Index (BMI) were more frequent in patients
with poor wellbeing at one and six months, although the associations
were not statistically significant. At baseline, on the other hand, vas-
cular disease and female sex were associated with a lower risk of poor
wellbeing. At six months, severe stroke at stroke onset also predicted
poor wellbeing. There was no apparent association between stroke
subtype or lesion location and poor wellbeing at any point. Genotype
distribution showed no deviation from the Hardy-Weinberg equilibrium
for the tri-allelic 5-HTTLPR and rs25531 genotypes (χ2-test, p = 0.40).
Likewise, there was no association between poor wellbeing and the
genotype expression groups at any point.
The mean WHO-5 score was 68.9 (SD 22.9) at baseline, 61.9 (23.3)
at one month, and 66.0 (23.4) at six months. Abnormal fatigue was
present in 328 (40.6%) at baseline, 394 (57.2%) at one month, and 288
(46.4%) at six months. Depression, defined as mild, moderate, or severe
according to ICD-10 criteria on the MDI, was present in 18 (2.1%) at
baseline, 42 (5.9%) at one month, and 33 (5.3%) at six months. At
baseline, 51 (5.5%) patients were being treated with antidepressants.
During the six months follow-up, 292 (31.8%) patients were being
treated with antidepressants. Fig. 1 shows a diagram of symptom
overlap with regard to poor wellbeing, abnormal fatigue, and depres-
sion at baseline and at one and six months. All depressed patients and
most patients experiencing poor wellbeing had an abnormal fatigue
score. The figure only includes patients completing all three ques-
tionnaires. Please see Table 2 for a complete overview of data included
A.G. Damsbo, et al. Journal of Affective Disorders 264 (2020) 358–364
359
Ta
bl
e
1
Pr
ed
ic
to
rs
of
po
or
w
el
lb
ei
ng
at
BA
SE
LI
N
E,
an
d
at
on
e
m
on
th
an
d
si
x
m
on
th
s
A
FT
ER
st
ro
ke
.
Ba
se
lin
e
O
ne
m
on
th
Si
x
m
on
th
s
N
=
85
6
C
ru
de
O
R
(9
5%
C
I)
M
ut
ua
lly
ad
ju
st
ed
O
R
(9
5%
C
I)
N
=
72
8
C
ru
de
O
R
(9
5%
C
I)
M
ut
ua
lly
ad
ju
st
ed
O
R
(9
5%
C
I)
N
=
64
8
C
ru
de
O
R
(9
5%
C
I)
M
ut
ua
lly
ad
ju
st
ed
O
R
(9
5%
C
I)
SE
R
T
ge
no
ty
pe
ex
pr
es
si
on
gr
ou
p
Lo
w
20
7
(2
4%
)
R
ef
.
R
ef
.
17
2
(2
4%
)
R
ef
.
R
ef
.
15
5
(2
4%
)
R
ef
.
R
ef
.
M
ed
iu
m
44
2
(5
2%
)
1
(0
.6
6
to
1.
49
)
0.
98
(0
.6
3
to
1.
5)
37
8
(5
2%
)
1.
28
(0
.8
5
to
1.
94
)
1.
25
(0
.8
1
to
1.
96
)
33
8
(5
2%
)
1.
52
(0
.9
8
to
2.
43
)
1.
54
(0
.9
5
to
2.
54
)
H
ig
h
20
7
(2
4%
)
1.
09
(0
.6
8
to
1.
76
)
0.
98
(0
.5
9
to
1.
63
)
17
8
(2
4%
)
1.
34
(0
.8
4
to
2.
15
)
1.
43
(0
.8
7
to
2.
37
)
15
5
(2
4%
)
1
(0
.5
8
to
1.
74
)
1.
07
(0
.5
9
to
1.
93
)
A
ge
Pe
r
10
ye
ar
s
85
6
(1
00
%
)
1.
15
(1
.0
2
to
1.
3)
1.
37
(1
.1
8
to
1.
61
)
72
8
(1
00
%
)
0.
91
(0
.8
1
to
1.
04
)
0.
84
(0
.7
2
to
0.
98
)
64
8
(1
00
%
)
0.
95
(0
.8
3
to
1.
09
)
0.
9
(0
.7
6
to
1.
07
)
Se
x
M
al
e
52
4
(6
1%
)
R
ef
.
R
ef
.
45
2
(6
2%
)
R
ef
.
R
ef
.
40
3
(6
2%
)
R
ef
.
R
ef
.
Fe
m
al
e
33
2
(3
9%
)
0.
65
(0
.4
7
to
0.
91
)
0.
52
(0
.3
5
to
0.
77
)
27
6
(3
8%
)
1.
48
(1
.0
7
to
2.
05
)
1.
34
(0
.9
2
to
1.
96
)
24
5
(3
8%
)
1.
34
(0
.9
3
to
1.
93
)
1.
22
(0
.7
9
to
1.
87
)
Bo
dy
M
as
s
In
de
x
<
18
.5
15
(2
%
)
0.
75
(0
.2
5
to
2.
79
)
0.
87
(0
.2
5
to
3.
62
)
11
(2
%
)
2.
29
(0
.6
7
to
8.
17
)
1.
58
(0
.4
1
to
6.
24
)
10
(2
%
)
4.
74
(1
.3
to
19
.2
6)
3.
74
(0
.8
7
to
17
.1
9)
18
.5
to
25
.0
26
1
(3
0%
)
R
ef
.
R
ef
.
21
5
(3
0%
)
R
ef
.
R
ef
.
18
3
(2
8%
)
R
ef
.
R
ef
.
>
25
.0
to
30
.0
25
8
(3
0%
)
1.
01
(0
.6
6
to
1.
54
)
1.
00
(0
.6
3
to
1.
59
)
22
9
(3
1%
)
0.
69
(0
.4
6
to
1.
04
)
0.
68
(0
.4
4
to
1.
06
)
20
6
(3
2%
)
1.
15
(0
.7
3
to
1.
83
)
1.
19
(0
.7
2
to
1.
99
)
ty
pe
=
"O
th
er
"
>
30
.0
18
3
(2
1%
)
1.
12
(0
.7
to
1.
79
)
1.
18
(0
.7
to
1.
98
)
15
1
(2
1%
)
0.
64
(0
.4
to
1.
01
)
0.
52
(0
.3
1
to
0.
86
)
13
7
(2
1%
)
1.
08
(0
.6
5
to
1.
81
)
0.
96
(0
.5
4
to
1.
69
)
U
nk
no
w
n
13
9
(1
6%
)
1.
08
(0
.6
6
to
1.
82
)
1.
77
(0
.9
1
to
3.
63
)
12
2
(1
7%
)
0.
68
(0
.4
1
to
1.
1)
0.
46
(0
.2
3
to
0.
86
)
11
2
(1
7%
)
0.
69
(0
.3
7
to
1.
23
)
0.
49
(0
.2
2
to
1.
02
)
Sm
ok
in
g
N
ev
er
27
3
(3
2%
)
R
ef
.
R
ef
.
24
3
(3
3%
)
R
ef
.
R
ef
.
21
9
(3
4%
)
R
ef
.
R
ef
.
Fo
rm
er
/o
cc
as
io
na
l
27
0
(3
2%
)
0.
92
(0
.5
9
to
1.
42
)
0.
85
(0
.5
3
to
1.
37
)
22
7
(3
1%
)
1.
1
(0
.7
3
to
1.
66
)
1.
23
(0
.7
8
to
1.
93
)
20
6
(3
2%
)
0.
75
(0
.4
7
to
1.
19
)
0.
77
(0
.4
6
to
1.
27
)
R
eg
ul
ar
25
4
(3
0%
)
0.
61
(0
.4
to
0.
92
)
0.
64
(0
.4
to
1.
02
)
20
6
(2
8%
)
1.
64
(1
.0
9
to
2.
47
)
1.
55
(0
.9
8
to
2.
44
)
17
7
(2
7%
)
1.
61
(1
.0
3
to
2.
5)
1.
64
(0
.9
9
to
2.
71
)
U
nk
no
w
n
59
(7
%
)
0.
69
(0
.3
6
to
1.
39
)
2.
42
(0
.5
5
to
15
.0
9)
52
(7
%
)
1.
33
(0
.6
7
to
2.
52
)
1.
35
(0
.3
3
to
4.
78
)
46
(7
%
)
0.
89
(0
.4
to
1.
86
)
1.
94
(0
.4
1
to
8.
01
)
A
lc
oh
ol
us
e
≤
14
(f
)/
21
(m
)
un
it
s/
w
ee
k
68
4
(8
0%
)
R
ef
.
R
ef
.
58
7
(8
1%
)
R
ef
.
R
ef
.
52
1
(8
0%
)
R
ef
.
R
ef
.
>
14
(f
)/
21
(m
)
un
it
s/
w
ee
k
10
6
(1
2%
)
0.
67
(0
.4
2
to
1.
08
)
0.
63
(0
.3
8
to
1.
07
)
83
(1
1%
)
1.
31
(0
.8
to
2.
13
)
1.
16
(0
.6
7
to
1.
97
)
76
(1
2%
)
1.
09
(0
.6
1
to
1.
85
)
1.
05
(0
.5
6
to
1.
89
)
U
nk
no
w
n
66
(8
%
)
0.
59
(0
.3
4
to
1.
06
)
0.
51
(0
.1
7
to
1.
56
)
58
(8
%
)
1.
26
(0
.6
9
to
2.
21
)
1.
21
(0
.4
to
3.
46
)
51
(8
%
)
0.
84
(0
.4
to
1.
62
)
0.
85
(0
.2
to
3.
05
)
Li
vi
ng
ar
ra
ng
em
en
t
W
it
h
so
m
eo
ne
54
2
(6
3%
)
R
ef
.
R
ef
.
48
0
(6
6%
)
R
ef
.
R
ef
.
43
5
(6
7%
)
R
ef
.
R
ef
.
A
lo
ne
27
0
(3
2%
)
0.
75
(0
.5
2
to
1.
07
)
0.
85
(0
.5
7
to
1.
28
)
21
0
(2
9%
)
1.
66
(1
.1
7
to
2.
36
)
1.
53
(1
.0
3
to
2.
28
)
17
7
(2
7%
)
1.
89
(1
.2
8
to
2.
77
)
1.
77
(1
.1
3
to
2.
76
)
U
nk
no
w
n
44
(5
%
)
0.
55
(0
.2
9
to
1.
13
)
1.
13
(0
.1
5
to
12
.4
8)
37
(5
%
)
1.
41
(0
.6
7
to
2.
83
)
6.
28
(0
.3
to
25
5.
4)
34
(5
%
)
0.
95
(0
.3
7
to
2.
15
)
3.
36
(0
.1
4
to
12
0.
06
)
D
ia
be
te
s
N
o
72
8
(8
5%
)
R
ef
.
R
ef
.
62
3
(8
6%
)
R
ef
.
R
ef
.
55
7
(8
6%
)
R
ef
.
R
ef
.
Y
es
85
(1
0%
)
0.
71
(0
.4
3
to
1.
22
)
0.
85
(0
.4
9
to
1.
54
)
66
(9
%
)
1.
46
(0
.8
5
to
2.
47
)
1.
39
(0
.7
6
to
2.
48
)
56
(9
%
)
1.
75
(0
.9
7
to
3.
1)
1.
66
(0
.8
5
to
3.
18
)
U
nk
no
w
n
43
(5
%
)
0.
64
(0
.3
3
to
1.
33
)
2.
36
(0
.2
to
14
6.
14
)
39
(5
%
)
1.
14
(0
.5
4
to
2.
25
)
0.
84
(0
.0
7
to
6.
54
)
35
(5
%
)
0.
65
(0
.2
4
to
1.
5)
0.
11
(0
to
2.
55
)
H
yp
er
te
ns
io
n
N
o
36
9
(4
3%
)
R
ef
.
R
ef
.
32
1
(4
4%
)
R
ef
.
R
ef
.
27
9
(4
3%
)
R
ef
.
R
ef
.
(c
on
tin
ue
d
on
ne
xt
pa
ge
)
A.G. Damsbo, et al. Journal of Affective Disorders 264 (2020) 358–364
360
Ta
bl
e
1
(c
on
tin
ue
d)
Ba
se
lin
e
O
ne
m
on
th
Si
x
m
on
th
s
N
=
85
6
C
ru
de
O
R
(9
5%
C
I)
M
ut
ua
lly
ad
ju
st
ed
O
R
(9
5%
C
I)
N
=
72
8
C
ru
de
O
R
(9
5%
C
I)
M
ut
ua
lly
ad
ju
st
ed
O
R
(9
5%
C
I)
N
=
64
8
C
ru
de
O
R
(9
5%
C
I)
M
ut
ua
lly
ad
ju
st
ed
O
R
(9
5%
C
I)
Y
es
44
7
(5
2%
)
0.
72
(0
.5
1
to
1.
02
)
0.
67
(0
.4
5
to
0.
99
)
37
1
(5
1%
)
1.
28
(0
.9
2
to
1.
79
)
1.
38
(0
.9
5
to
2.
01
)
33
6
(5
2%
)
1.
27
(0
.8
8
to
1.
85
)
1.
28
(0
.8
4
to
1.
97
)
U
nk
no
w
n
40
(5
%
)
0.
5
(0
.2
5
to
1.
07
)
0.
2
(0
to
11
.6
)
36
(5
%
)
1.
24
(0
.5
6
to
2.
57
)
1.
18
(0
.0
1
to
54
.3
6)
33
(5
%
)
0.
76
(0
.2
7
to
1.
81
)
0.
64
(0
to
38
.2
2)
Pe
ri
ph
er
al
ar
te
ri
al
di
se
as
e
N
o
76
9
(9
0%
)
R
ef
.
R
ef
.
65
7
(9
0%
)
R
ef
.
R
ef
.
58
2
(9
0%
)
R
ef
.
R
ef
.
Y
es
41
(5
%
)
0.
91
(0
.4
4
to
2.
07
)
1.
03
(0
.4
6
to
2.
51
)
31
(4
%
)
1.
83
(0
.8
6
to
3.
79
)
1.
21
(0
.5
1
to
2.
81
)
30
(5
%
)
1.
3
(0
.5
6
to
2.
83
)
0.
83
(0
.3
1
to
2.
08
)
U
nk
no
w
n
46
(5
%
)
0.
65
(0
.3
4
to
1.
31
)
1.
13
(0
.1
4
to
16
.6
4)
40
(5
%
)
1.
09
(0
.5
2
to
2.
13
)
1.
48
(0
.1
2
to
12
.1
8)
36
(6
%
)
0.
73
(0
.2
9
to
1.
62
)
1.
4
(0
.0
6
to
19
.6
1)
V
as
cu
la
r
di
se
as
es
*
N
o
57
7
(6
7%
)
R
ef
.
R
ef
.
49
3
(6
8%
)
R
ef
.
R
ef
.
43
1
(6
7%
)
R
ef
.
R
ef
.
Y
es
23
0
(2
7%
)
0.
55
(0
.3
8
to
0.
79
)
0.
39
(0
.2
5
to
0.
61
)
19
3
(2
7%
)
1.
26
(0
.8
8
to
1.
8)
1.
56
(1
.0
0
to
2.
42
)
17
9
(2
8%
)
1.
29
(0
.8
6
to
1.
9)
1.
35
(0
.8
2
to
2.
21
)
U
nk
no
w
n
49
(6
%
)
0.
53
(0
.2
8
to
1.
05
)
0.
51
(0
.1
to
3.
62
)
42
(6
%
)
0.
92
(0
.4
3
to
1.
83
)
0.
11
(0
to
1.
45
)
38
(6
%
)
0.
73
(0
.2
9
to
1.
61
)
1.
44
(0
.0
6
to
13
.5
2)
SS
S
sc
or
e
45
to
58
58
3
(6
8%
)
R
ef
.
R
ef
.
50
8
(7
0%
)
R
ef
.
R
ef
.
46
3
(7
1%
)
R
ef
.
R
ef
.
30
to
44
15
4
(1
8%
)
0.
83
(0
.5
4
to
1.
28
)
0.
69
(0
.4
3
to
1.
12
)
12
4
(1
7%
)
0.
91
(0
.5
8
to
1.
4)
0.
88
(0
.5
2
to
1.
45
)
10
3
(1
6%
)
1.
08
(0
.6
5
to
1.
76
)
1.
07
(0
.6
to
1.
85
)
15
to
29
62
(7
%
)
0.
76
(0
.4
2
to
1.
45
)
0.
56
(0
.2
7
to
1.
2)
47
(6
%
)
1.
7
(0
.9
1
to
3.
12
)
1.
97
(0
.9
4
to
4.
07
)
39
(6
%
)
1.
8
(0
.8
8
to
3.
53
)
3.
14
(1
.3
6
to
7.
16
)
0
to
14
17
(2
%
)
1.
13
(0
.3
6
to
4.
98
)
0.
6
(0
.1
5
to
3.
16
)
13
(2
%
)
0.
75
(0
.1
7
to
2.
5)
0.
65
(0
.1
1
to
2.
88
)
10
(2
%
)
2.
14
(0
.5
4
to
7.
62
)
4.
35
(0
.8
3
to
21
.5
5)
U
nk
no
w
n
40
(5
%
)
0.
57
(0
.2
9
to
1.
19
)
0.
61
(0
.0
1
to
33
.7
8)
36
(5
%
)
1.
1
(0
.5
1
to
2.
24
)
0.
67
(0
.0
1
to
30
.9
2)
33
(5
%
)
0.
71
(0
.2
6
to
1.
66
)
0.
76
(0
to
47
.3
4)
Th
ro
m
bo
ly
si
s
N
o
49
9
(5
8%
)
R
ef
.
R
ef
.
40
9
(5
6%
)
R
ef
.
R
ef
.
35
7
(5
5%
)
R
ef
.
R
ef
.
Y
es
29
0
(3
4%
)
1.
21
(0
.8
4
to
1.
75
)
1.
26
(0
.8
3
to
1.
93
)
26
1
(3
6%
)
0.
73
(0
.5
1
to
1.
03
)
0.
71
(0
.4
7
to
1.
06
)
23
9
(3
7%
)
0.
75
(0
.5
to
1.
1)
0.
7
(0
.4
4
to
1.
09
)
U
nk
no
w
n
67
(8
%
)
0.
81
(0
.4
6
to
1.
5)
1.
41
(0
.3
4
to
8.
66
)
58
(8
%
)
1.
27
(0
.7
1
to
2.
25
)
2.
2
(0
.5
3
to
8.
44
)
52
(8
%
)
1.
02
(0
.5
1
to
1.
92
)
2.
36
(0
.5
4
to
9.
56
)
Th
ro
m
be
ct
om
y
N
o
74
1
(8
7%
)
R
ef
.
R
ef
.
62
9
(8
6%
)
R
ef
.
R
ef
.
56
0
(8
6%
)
R
ef
.
R
ef
.
Y
es
56
(7
%
)
1.
59
(0
.7
8
to
3.
69
)
1.
87
(0
.7
8
to
4.
9)
50
(7
%
)
1.
19
(0
.6
3
to
2.
18
)
1.
02
(0
.4
4
to
2.
25
)
43
(7
%
)
0.
92
(0
.4
2
to
1.
85
)
0.
74
(0
.2
8
to
1.
84
)
U
nk
no
w
n
59
(7
%
)
0.
71
(0
.4
to
1.
33
)
0.
67
(0
.0
8
to
4.
41
)
49
(7
%
)
1.
35
(0
.7
1
to
2.
46
)
1.
08
(0
.1
8
to
6.
81
)
45
(7
%
)
0.
98
(0
.4
6
to
1.
93
)
1.
34
(0
.2
to
9.
17
)
O
xf
or
ds
hi
re
C
la
ss
ifi
ca
ti
on
(%
)
To
ta
l
an
te
ri
or
ci
rc
ul
at
io
n
in
fa
rc
t
60
(7
%
)
R
ef
.
R
ef
.
42
(6
%
)
R
ef
.
R
ef
.
34
(5
%
)
R
ef
.
R
ef
.
Pa
rt
ia
l
an
te
ri
or
ci
rc
ul
at
io
n
in
fa
rc
t
25
1
(2
9%
)
0.
65
(0
.3
to
1.
32
)
0.
47
(0
.1
8
to
1.
12
)
21
1
(2
9%
)
0.
97
(0
.4
8
to
2.
04
)
1.
18
(0
.4
8
to
3.
02
)
20
3
(3
1%
)
0.
86
(0
.3
9
to
2.
06
)
1.
48
(0
.5
4
to
4.
42
)
Po
st
er
io
r
ci
rc
ul
at
io
n
in
fa
rc
t
12
7
(1
5%
)
0.
68
(0
.2
9
to
1.
46
)
0.
54
(0
.2
to
1.
37
)
10
7
(1
5%
)
0.
83
(0
.3
8
to
1.
85
)
0.
93
(0
.3
6
to
2.
5)
10
0
(1
5%
)
1.
08
(0
.4
6
to
2.
71
)
2
(0
.6
8
to
6.
29
)
La
cu
na
r
in
fa
rc
t
13
9
(1
6%
)
0.
7
(0
.3
to
1.
49
)
0.
5
(0
.1
7
to
1.
44
)
12
2
(1
7%
)
1.
01
(0
.4
8
to
2.
2)
1.
36
(0
.4
7
to
4.
07
)
10
9
(1
7%
)
1.
01
(0
.4
3
to
2.
51
)
2.
12
(0
.6
2
to
7.
58
)
U
nd
et
er
m
in
ed
19
(2
%
)
0.
22
(0
.0
7
to
0.
68
)
0.
21
(0
.0
5
to
0.
76
)
14
(2
%
)
1.
24
(0
.3
3
to
4.
36
)
1.
15
(0
.2
4
to
5.
08
)
11
(2
%
)
1.
04
(0
.2
to
4.
57
)
1.
58
(0
.2
2
to
9.
31
)
U
nk
no
w
n
26
0
(3
0%
)
1.
07
(0
.4
8
to
2.
2)
0.
71
(0
.1
6
to
3.
4)
23
2
(3
2%
)
0.
81
(0
.4
to
1.
71
)
2.
24
(0
.5
5
to
9.
21
)
19
1
(2
9%
)
0.
81
(0
.3
6
to
1.
95
)
3.
59
(0
.7
4
to
17
.7
)
TO
A
ST
cl
as
si
fi
ca
ti
on
(%
)
La
rg
e-
ar
te
ry
at
he
ro
sc
le
ro
si
s
12
2
(1
4%
)
R
ef
.
R
ef
.
10
4
(1
4%
)
R
ef
.
R
ef
.
90
(1
4%
)
R
ef
.
R
ef
.
(c
on
tin
ue
d
on
ne
xt
pa
ge
)
A.G. Damsbo, et al. Journal of Affective Disorders 264 (2020) 358–364
361
in the visualization.
At baseline, 63 (6.9%) did not complete the WHO-5, whereas 77
(8.4%) did not complete the MDI, and 112 (12.2%) missed the MFI. In
total, 778 (84.7%) had complete questionnaires. After one month, 191
(20.8%) did not complete the questions related to WHO-5, 212 (23.1%)
did not complete the MDI, and 230 (25%) did not complete the MFI. A
total of 649 (70.6%) patients completed the WHO-5, the MDI, and the
MFI after one month. At the last follow-up after six months, 271
(29.5%) were missing the WHO-5, 297 (32.3%) the MDI, and 298
(32.4%) the MFI. The number of patients who completed the wellbeing,
depression, and fatigue scales was 578 (62.9%).
Sensitivity analyses of predictors for poor wellbeing using imputa-
tion on missing data showed similar results (data not shown). In sen-
sitivity analyses excluding patients treated with antidepressants and in
analyses excluding patients treated with antidepressants and patients
with possible depression according to the MDI, vascular disease was
associated with poor wellbeing at one month. Living alone, severe
stroke, and smoking at stroke onset were all independently associated
with poor wellbeing at six months (ONLINE SUPPLEMENT).
4. Discussion
We examined predictors of wellbeing and the degree of overlap
between well-defined aspects of mental health after stroke in a middle-
aged stroke cohort with stroke of mild to moderate grade. Living alone
at stroke onset was the strongest predictor of poor wellbeing, but stroke
severity at baseline also negatively affected reported wellbeing. In
sensitivity analyses excluding depressed patients and patients treated
with antidepressants, vascular disease and smoking also predicted poor
wellbeing. All patients with depression and most patients with low
wellbeing suffered from abnormal fatigue. Mental health problems
were most pronounced at one month but were also present at baseline.
Previous studies examining predictors of depression after stroke
report that physical disability, stroke severity, history of depression,
and cognitive impairment are the most consistent predictors of poor
wellbeing (Towfighi et al., 2017). The present study is, to the best of
our knowledge, the first study to explore predictors, including SERT
gene polymorphisms, of poor wellbeing after stroke. Living alone was
the strongest predictor for low wellbeing one and six months after
stroke. Previous studies report conflicting results on the association
between living alone and PSD (Johnson et al., 2006). A recent study in
males from the general population found that living alone was an in-
dependent predictor of all-cause mortality and cardiovascular mortality
(Jensen et al., 2019). As a growing number of people are living alone,
these results emphasize the importance of initiatives targeting psy-
chosocial interventions.
We conducted analyses without patients with depression and pa-
tients treated with antidepressants. In these analyses, living alone re-
mained the strongest predictor of poor wellbeing. This indicates that
our results do not solely reflect an underlying association between de-
pression and poor wellbeing. The sensitivity analyses further indicate
that vascular disease and vascular risk factors, such as smoking at
baseline, are predictors of poor wellbeing after stroke. Secondary pre-
vention targeting vascular risk factors may thus further help prevent
poor wellbeing and optimize the recovery process after stroke. It should
be noted that we had no information on smoking status during follow-
up, and smoking cessation after stroke may have affected wellbeing.
Examining the overlap between wellbeing, fatigue, and depression
revealed that regardless of the absence of depression, patients may
experience poor mental health and other symptoms such as fatigue
which may affect their quality of life and potentially reduce their
chance of optimal recovery. This is in line with the results from pre-
vious studies, indicating that abnormal fatigue may be present even in
the face of well-treated depression (Andersen et al., 2012; Wu et al.,
2015). Not all patients with depression are being treated effectively or
sufficiently with antidepressants. The need for additional, targetedTa
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psychosocial intervention with a broader focus than depression must be
considered in each patient. Consequently, a focus on all aspects of
mental health is important in post-stroke care with such care ideally
being provided via a multifaceted intervention.
We found that poor mental health, depression, and fatigue were
most frequently present one month after stroke, but mental health
problems were also present at baseline. The mean WHO-5 wellbeing
score of 68.9 at baseline is comparable to that of the general Danish
population (mean score 70) (Topp et al., 2015). Using ICD-10 criteria,
previous studies have reported a prevalence of pre-stroke depression
and fatigue among older adults similar to the figures reported here
(Choi-Kwon et al., 2005; Lerdal et al., 2011; Sjöberg et al., 2017). The
relatively high prevalence of mental health problems at baseline may,
however, at least in part be caused by recall bias as patients were asked
to report on pre-stroke symptoms immediately following a potentially
life-changing event. Another possible explanation for the high pre-
valence of mental health problems could be pre-existing and “asymp-
tomatic” chronic cerebrovascular lesions, e.g. white matter lesions and
microbleeds, preceding the symptomatic stroke, which would increase
the prevalence of mental health problems also before stroke onset.
Identifying stroke patients from population-based studies where in-
formation on mental health has been registered prior to stroke onset
could overcome the issue of recall bias in future studies.
5. Limitations
The relatively small number of participants limited our study,
especially with respect to studying the association of wellbeing with the
SERT genotype, but also other potential predictors such as stroke sub-
type where we had a high percentage of patients with an unknown
Oxfordshire and TOAST classification. Patients for whom information
on stroke subtype was available were consecutive, and the distribution
of stroke sub-type in this group is likely to be representative of the
entire cohort. The risk of a type II error is present, however, and could
falsely infer the absence of otherwise relevant associations. A third
polymorphism in the serotonin transporter gene, STin2 VNTR (variable
Table 2
Test results and test completion at BASELINE, and at one month and six months AFTER stroke.
Fatigue* Depression* Low wellbeing* Complete cases Non-complete cases
Baseline 318 (40.9%) 18 (2.3%) 166 (21.3%) 778 (84.7%) 141 (15.3%)
One month 364 (56.1%) 36 (5.5%) 186 (28.7%) 649 (70.6%) 270 (29.4%)
Six months 268 (46.4%) 31 (5.4%) 135 (23.4%) 578 (62.9%) 341 (37.1%)
⁎ Data include patients with completed questionnaires only, corresponding to Fig. 1.
Fig. 1. Symptom overlap
Visualization of symptom overlap at baseline, and after one and six months. Includes patients with completed questionnaires only.
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number of tandem repeats in intron 2), has been associated with PSD
(Kohen et al., 2008). Significant adjustments to our laboratory set-up
were required, if we were to analyze this polymorphism. Furthermore,
no significant association between this polymorphism and PSD was
found in the meta-analysis by Mak et al. (2013). Depression was not
diagnosed using a diagnostic interview; however, the MDI can be used
to generate an ICD-10 diagnosis of moderate to severe depression for
research purpose and not only to estimate symptom severity
(Bech et al., 2001). In the present study, we focused on patient-reported
outcomes for which purpose the MDI is an appropriate tool. The WHO-5
may be used as a screening tool for depression, but it was chosen as a
measure of subjective wellbeing as its positive wording reflects overall
mental health (Topp et al., 2015). There was not complete follow-up on
all patients, and not all patients filled in all questionnaires at each
follow-up. Likely, patients with the most pronounced symptoms of de-
pression, fatigue, and mood disorder were less prone to fill in and re-
turn the questionnaires. This would have led us to underestimate the
presence of symptoms. Finally, we had no information on other aspects
that could affect wellbeing after stroke such as functional outcome,
cognitive impairment, pain, and the ability to return to work.
6. Conclusion
In conclusion, living alone most strongly predicted poor wellbeing
after stroke. We found no association between serotonin transporter
gene polymorphisms and wellbeing after stroke; however, larger scaled
studies are warranted to study this association further. Despite a low
prevalence of depression, abnormal fatigue and poor wellbeing were
common. All depressed patients and most patients with poor wellbeing
had abnormal fatigue. Mental health after stroke is complex, and our
findings emphasize the importance of adopting a wide approach to the
assessment and management as well as the need for applying a targeted
psychosocial intervention. Antidepressant treatment is important when
indicated, but it cannot stand alone.
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